Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.5 USD | -1.07% |
|
+2.74% | +20.62% |
01:45am | Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer | CI |
06-26 | Merck: US approval for canine flu vaccine | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.62% | 333B | |
+54.61% | 811B | |
+43.76% | 640B | |
-6.33% | 353B | |
+10.44% | 302B | |
+18.11% | 246B | |
+2.66% | 225B | |
+12.90% | 218B | |
+8.61% | 168B | |
-4.76% | 155B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Insider Sell: Merck & Co.